is semaglutide off the shortage list on taken As of February 21, 2025, FDA updated its drug list Semaglutide and Tirzepatide off FDA As GLP-1 Drug Shortage Ends,

A 2025 network meta-analysis ranked nausea risk as follows: orforglipron (highest, relative risk 4.77), liraglutide (3.09), semaglutide (2.94), tirzepatide (2.89), exenatide (2.66), and cagrilintide (2.29)

Second, the gastroparesis PRR comparison (9.41 vs 4.40) is based on extremely small event counts (n=6 and n=5), making the confidence intervals wide and the comparison statistically fragile

Intracellular proatherogenic events and cell adhesion modulated by extracellular thiol/disulfide redox state

C Nature Metabolism.2025

Some prolonged shoulder injuries after vaccination are associated with SIRVA (Shoulder Injury Related to Vaccine Administration), a condition that can occur when the injection is administered too high or too deep into the shoulder area